MedTrace Logo

Hypertension and Diabetes Assessment in the Rohingya Refugee Population and in the Host Communities in Bangladesh

NCT04307875 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2021-04-28

No results posted yet for this study

Summary

Due to a massive outbreak of violence against the Rohingya minority residing in the Rakhine State of Myanmar in late 2017, several hundred thousand Rohingya fled the country and sought a shelter in Bangladesh. Currently, in the refugee settlement areas east of the city of Cox's Bazar, close to 1 million Rohingya refugees live in refugee camps close to the municipalities of Ukhia and Shamlapur.

According to previous examinations, there is a serious burden of non-communicable diseases in Bangladesh. But little is known about the health status and the epidemiology of non-communicable diseases in the Rohingya refugee population in Bangladesh. Most importantly, scientific evidence on non-communicable disease in humanitarian emergencies is rather limited.

The aim of this study is to close this gap and to systematically assess the burden of hypertension and diabetes within the Rohingya refugee population in refugee camps in Bangladesh and in the host community in the Chittagong province. This assessment will help to design and to introduce community-based intervention strategies aiming to improve the population health status and reduce the disease burden.

Conditions

Interventions

DIAGNOSTIC_TEST

Blood pressure measurement (sphygmomanometer)

measuring blood pressure with standard sphygmomanometer

DIAGNOSTIC_TEST

Blood glucose measurement

measuring blood glucose using standard measurement devices

OTHER

psychometric tests

WHODAS 2.0, PHQ-9, CAPS-5

Sponsors & Collaborators

  • Heidelberg University

    collaborator OTHER

  • Gono Bishwabidyalay

    collaborator UNKNOWN

  • Gonoshasthaya Kendra

    collaborator UNKNOWN

  • University Hospital Freiburg

    lead OTHER

Principal Investigators

  • Kashem Shaikh, PhD · Gono Bishwabidyalay

  • Alexander Supady, Dr. med. MPH · University of Freiburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-05-15
Completion
2022-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04307875 on ClinicalTrials.gov